4 Pillars Toolkit for Adolescent Vaccination
Completed · Not applicable
Conditions studied: Adolescent HPV Vaccine, Adolescent Influenza Vaccine
In brief
The purpose of this study is to test whether or not the 4 Pillars Immunization Toolkit increases adolescent vaccination rates, particularly influenza and human papillomavirus (HPV) but also tetanus, diphtheria and pertussis (Tdap), and meningococcal conjugate (MCV) vaccination rates. The vaccines are all FDA licensed vaccines and to be used according to national guidelines. The investigators will conduct a randomized cluster trial of this toolkit in diverse primary care practices with electronic medical records (EMRs).
Key facts
- Study ID
- NCT02165722
- Run by
- University of Pittsburgh
- People needed
- 22
- Starts
- 2013-09-01
- Expected to finish
- 2016-12-01
- Last updated by the study team
- 2018-08-28
Who can join
Age: 11 and older, up to 17. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- For clinical sites: inclusion criterion includes
- an appropriate adolescent population: e.g., adolescents aged 11 to 17 years
- currently using an EMR
- having and keeping immunization data within a EMR or registry.
You may not qualify if…
- For clinical sites: the exclusion criteria is consistent SOP use for the vaccines being studied or known much higher than average immunization rates.
Where it is running
- University of Pittsburgh, School of Medicine, Department of Family Medicine — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.